Traditional Chinese medicine:research and development,globalization,and regulation 被引量：3

Traditional Chinese medicine: research and development, globalization, and regulation

导出

摘要 In this issue of Chinese Journal of Natural Medicines （CJNM）, we are pleased to publish two comprehensive and timely review articles [1-2] addressing the registration regulation of traditional Chinese medicine （TCM）, a critical issue in the development, regulation, and internationalization of TCM.

作者 ZHANG Rui-Wen

机构地区 Associate Editor-In-Chief Chinese Journal of Natural Medicines Department of Pharmaceutical Sciences

出处《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2017年第1期1-3,共3页 中国天然药物（英文版）

关键词 TCM research and development Traditional Chinese medicine SFDA

分类号 R [医药卫生]

引文网络
相关文献

参考文献9

1李梢,张博.中药网络药理学:理论、方法与应用(英文)[J].中国天然药物,2013,11(2):110-120. 被引量：381
2ZI Tian,YU Dong.A network pharmacology study of Sendeng-4,a Mongolian medicine[J].Chinese Journal of Natural Medicines,2015,13(2):108-118. 被引量：12
3YUAN Lin,WU Zhi-Ang,SHAO Ming-Li.Evolution of the registration regulations for proprietary Chinese medicines in China[J].Chinese Journal of Natural Medicines,2017,15(1):4-11. 被引量：1
4YAN Shi-Kai,LIU Run-Hui,JIN Hui-Zi,LIU Xin-Ru,YE Ji,SHAN Lei,ZHANG Wei-Dong.“Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives[J].Chinese Journal of Natural Medicines,2015,13(1):3-21. 被引量：18
5WU Wan-Ying,HOU Jin-Jun,LONG Hua-Li,YANG Wen-Zhi,LIANG Jian,GUO De-An.TCM-based new drug discovery and development in China[J].Chinese Journal of Natural Medicines,2014,12(4):241-250. 被引量：16
6JIANG Yu,XIA Jun-Ping,YANG Jian-Hong,ZHANG Zhe-Feng,HU Chang-Qin,ZHANG Zhi-Rong.Guidelines and strategy of the International Conference of Harmonization(ICH) and its member states to overcome existing impurity control problems for antibiotics in China[J].Chinese Journal of Natural Medicines,2015,13(7):498-506. 被引量：1
7WANG Xiao-Bin.Pharmaceutical innovation and advancement of Clinical therapy and public health:enlightenment from artemisinin development[J].Chinese Journal of Natural Medicines,2016,14(1):3-4. 被引量：2
8David T. Graham.Regulation of proprietary traditional Chinese medicines in Australia[J].Chinese Journal of Natural Medicines,2017,15(1):12-14. 被引量：5
9ZHANG Rui-Wen.Artemisinin (Qinghaosu), Nobel Prize, anti-malaria, and beyond[J].Chinese Journal of Natural Medicines,2016,14(1):1-2. 被引量：2

二级参考文献39

1QIAN Zhong-zhi1,DAN Yang2,LIU Yan-ze2,PENG Yong2 1.Chinese Pharmacopoeia Commission,Beijing 100061,China 2.Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences,Beijing 100193,China.Pharmacopoeia of the People's Republic of China(2010 Edition):A Milestone in Development of China's Healthcare[J].Chinese Herbal Medicines,2010,2(2):157-160. 被引量：56
2ZHU Wei,QIU XiaoHui,XU XiaoJie,LU ChuanJian.Computational network pharmacological research of Chinese medicinal plants for chronic kidney disease[J].Science China Chemistry,2010,53(11):2337-2342. 被引量：13
3王广良,陈成彬,高建明,倪虹,王同顺,陈力.细胞周期相关基因微阵列在中药抑制肝癌细胞增殖作用机理研究中的应用[J].中国中药杂志,2005,30(1):50-54. 被引量：13
4陈祝安,刘广玉,胡菽英.蝉花的人工培养及其药理作用研究[J].真菌学报,1993,12(2):138-144. 被引量：66
5袁雯玮.高分子聚合物研究与中国药典2005年版β-内酰胺类抗生素高分子聚合物修订情况及操作要点[J].中国抗生素杂志,2005,30(12):727-730. 被引量：47
6孙燕,林洪生,朱允中,冯继锋,陈正堂,李攻戍,张湘茹,张宗岐,唐俊舫,史美祺,郝学志,韩慧.长春瑞滨合并顺铂(NP)加参一胶囊或安慰剂治疗晚期非小细胞肺癌的多中心双盲随机临床研究报告[J].中国肺癌杂志,2006,9(3):254-258. 被引量：80
7赵春芳,刘金平,李平亚.西洋参果肉药用的研究[J].时珍国医国药,2007,18(1):115-116. 被引量：3
8李梢.基于生物网络调控的方剂研究模式与实践[J].中西医结合学报,2007,5(5):489-493. 被引量：87
9LI Lin,WANG JianNong,REN JianXun,XIANG JunFeng,TANG YaLin,LIU JianXun,HANDing.Metabonomics analysis of the urine of rats with Qi deficiency and blood stasis syndrome based on NMR techniques[J].Chinese Science Bulletin,2007,52(22):3068-3073. 被引量：21
10www.nobelprize.org. Accessed on December 8, 2015.

共引文献426

1陈明骏,高路,仝战旗.基于肾素-血管紧张素系统筛选治疗新型冠状病毒肺炎有效中药的网络药理学研究[J].中药材,2020(5):1291-1296. 被引量：2
2程林辉,陈兰英,寿斌耀,罗颖颖,崔亚茹,刘荣华.基于网络药理学和实验验证交趾黄檀心材调控能量代谢治疗心肌缺血分子机制[J].中国中药杂志,2022,47(24):6696-6708. 被引量：4
3孙凯,朱立国,魏戌,张平,展嘉文,王源,银河.基于网络药理学的“淫羊藿-白芍”配伍治疗腰椎间盘突出症作用机制研究[J].中国中药杂志,2020,45(3):609-616. 被引量：27
4何信用,郑思成,王群,吴佳蔓,陈文娜,张哲.基于网络药理学的黄连解毒汤治疗动脉粥样硬化的潜在分子机制研究[J].中草药,2020,51(3):687-696. 被引量：19
5蒋彤,方亮,岳宏,尹艳亮,雒宏琳,蒋峰.基于网络药理学理论的系统营养联合节律运动对肝代谢异常人群的干预研究[J].慢性病学杂志,2020,0(1):7-9. 被引量：4
6王单单,郭丽娜,裴媛,王博,王瑞.基于网络药理学的半枝莲-白花蛇舌草药对作用机制分析[J].药物评价研究,2020,0(2):206-212. 被引量：18
7罗虹,刘凯丽,王艳.“远志-石菖蒲”药对治疗阿尔茨海默病的作用机制研究[J].亚太传统医药,2020,0(1):163-167. 被引量：8
8许禄华,周旭,蒋峰,李亮,宋银枝,曾志聪,吴子君,林丰夏.保元活络方改善心肌缺血再灌注损伤的作用机制预测及验证[J].中国现代应用药学,2022,39(3):300-311. 被引量：5
9钟晓莹,陈国铭,赵金龙,於菁雯,李丹,张洁,黄雁,綦向军,刘敏.苓桂术甘汤治疗慢性心衰的靶点预测与机制探讨[J].时珍国医国药,2018,29(11):2792-2797. 被引量：16
10皇甫海全,黄慧春,商晓明,黄智超,廖蔚茜,于海睿.基于网络药理学及实验验证养心汤抗动脉粥样硬化作用机制研究[J].世界科学技术-中医药现代化,2024,26(4):1070-1079.

同被引文献21

1郭希清,叶婧,李金钢.虎骨及其替代品的研究进展[J].陕西师范大学学报（自然科学版）,2006,34(B03):218-221. 被引量：11
2崔翰明,张春光,林海,路文龙,程慧平,王阶.HPLC法测定三七不同药用部位中有效成分含量[J].中药材,2009,32(12):1810-1813. 被引量：32
3焦士勇,艾常虹,李艾芳,李桦,王旗.补骨脂酚的体外肝微粒体代谢及代谢减毒作用的种属比较[J].中国药理学通报,2011,27(2):216-220. 被引量：17
4张培培,周勤梅,秦波,姚志昂,彭成,郭力.川贝母栽培品瓦布贝母与松贝母的总生物碱对比研究[J].成都中医药大学学报,2011,34(1):70-72. 被引量：11
5钟玉环,沈国林,原梅,刘万卉,李桦.补骨脂素和异补骨脂素对体外细胞色素P450酶活性的抑制和诱导作用[J].中国药理学与毒理学杂志,2012,26(4):522-528. 被引量：17
6张辉,孙佳明,林喆,王淑敏,姜大成,李宜平.药用动物资源研究开发及可持续利用[J].中国现代中药,2014,16(9):717-723. 被引量：18
7David T. Graham.Regulation of proprietary traditional Chinese medicines in Australia[J].Chinese Journal of Natural Medicines,2017,15(1):12-14. 被引量：5
8李晗,王宇光,马增春,谭洪玲,肖成荣,汤响林,张伯礼,高月.补骨脂素、异补骨脂素、补骨脂二氢黄酮与异补骨脂查尔酮对CYP2B6诱导作用研究[J].中药药理与临床,2017,33(1):15-19. 被引量：2
9GE Guang-Bo.Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system[J].Chinese Journal of Natural Medicines,2019,17(11):801-802. 被引量：9
10CHEN Lu-Lin,CHEN Can-Hui,ZHANG Xing-Xian,WANG Yi,WANG Shu-Fang.Identification of constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS combined with LC-Q-TOF-MS and elucidation of their metabolic networks in rat plasma after oral administration[J].Chinese Journal of Natural Medicines,2019,17(11):803-821. 被引量：11

引证文献3

1GE Guang-Bo.Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system[J].Chinese Journal of Natural Medicines,2019,17(11):801-802. 被引量：9
2ZHOU Qi-Hang,ZHU Ya-Di,ZHANG Feng,SONG Yun-Qing,JIA Shou-Ning,ZHU Liang,FANG Sheng-Quan,GE Guang-Bo.Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus[J].Chinese Journal of Natural Medicines,2019,17(11):858-870. 被引量：11
3GONG Jiahao,LI Haiying,XU Jianguang,CHEN Hongzhuan,GE Guangbo.Sustainable utilization of precious Chinese medicines:challenges and the road ahead[J].Chinese Journal of Natural Medicines,2022,20(11):801-804.

二级引证文献14

1陈露,白跃,陈悉,侯旭东,臧师竹,吴大畅,侯洁.蜜桑白皮的体内降脂作用研究[J].世界科学技术-中医药现代化,2021,23(9):3337-3343. 被引量：4
2GE Guang-Bo.Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system[J].Chinese Journal of Natural Medicines,2019,17(11):801-802. 被引量：9
3HOU Xu-Dong,SONG Li-Lin,CAO Yun-Feng,WANG Yi-Nan,ZHOU Qi,FANG Sheng-Quan,WU Da-Chang,ZANG Shi-Zhu,CHEN Lu,BAI Yue,GE Guang-Bo,HOU Jie.Pancreatic lipase inhibitory constituents from Fructus Psoraleae[J].Chinese Journal of Natural Medicines,2020,18(5):369-378. 被引量：7
4于玲,肖芳,侯继秋,慕萧萧,曲凌萱,陈康,王冬雪.白癜风丸致重度肝损伤1例[J].中国药物应用与监测,2020,17(3):207-209. 被引量：1
5马丽娟,霍鹏超,孙梦茹,朱亮,胡情,葛广波,贾守宁.黑果枸杞化学成分和药理活性的研究进展[J].中草药,2020,51(22):5884-5893. 被引量：24
6刘伟,秦柯,张彦忠,白素平.基于网络药理学探讨补骨脂潜在肝毒性机制[J].中国药物警戒,2020,17(12):849-855. 被引量：5
7Fang-Yuan Wang,Ping Wang,Dong-Fang Zhao,Frank J.Gonzalez,Yu-Fan Fan,Yang-Liu Xia,Guang-Bo Ge,Ling Yang.Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications[J].Journal of Pharmaceutical Analysis,2021,11(1):15-27. 被引量：1
8姜波,石美智,陈君君,杨姣,张科之,郭澄,韩永龙.体外系统性评价79种中药注射剂对9种人细胞色素P450酶的抑制作用[J].药学学报,2021,56(1):274-282. 被引量：2
9HONG Zong-Chao,CAI Quan,WU He-Zhen,YANG Yan-Fang,FAN Heng,DUAN Xue-Yun.Compound Sophorae Decoction:treating ulcerative colitis by affecting multiple metabolic pathways[J].Chinese Journal of Natural Medicines,2021,19(4):267-283. 被引量：5
10LIU Wei,HUANG Jian,ZHANG Feng,ZHANG Cong-Cong,LI Rong-Sheng,WANG Yong-Li,WANG Chao-Ran,LIANG Xin-Miao,ZHANG Wei-Dong,YANG Ling,LIU Ping,GE Guang-Bo.Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS[J].Chinese Journal of Natural Medicines,2021,19(4):305-320. 被引量：12

1Jing-wen Cao,Lu Zhang,Ye Li,Qing Yang,Wen-hua Fu,Xiao-chen Wang,Wen-long Huang.Trends and Prospects of Stem Cell Research in China[J].Chinese Medical Sciences Journal,2016,31(2):116-120.
2EIGHT SERIES HEALTH PRODUCTS OF QIN DRAGON ONCE A CUSTOMER,FRIENDS FOREVER[J].外科研究与新技术,1993,0(2):127-128.
3秦菁.An Overview on Intercultural Communication Based on Gray’s Anatomy S2[J].青春岁月,2015(17):236-237.
4James L．Week.尘肺预防策略[J].中华劳动卫生职业病杂志,2007,25(3):184-186. 被引量：1
5The potential therapeutic effect DL0805-2 on experimental pulmonary hypertensive rats and the underlying mechanisms[J].中国药理学通报,2015,31(B11):60-61.

Chinese Journal of Natural Medicines

2017年第1期

浏览历史

内容加载中请稍等...